A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma
Amber K. Weiner, Alexander B. Radaoui, Matthew Tsang, Daniel Martinez, Simone Sidoli, Karina L. Conkrite, Alberto Delaidelli, Apexa Modi, Jo Lynne Rokita, Khushbu Patel, Maria V. Lane, Bo Zhang, Chuwei Zhong, Brian Ennis, Daniel P. Miller, Miguel A. Brown, Komal S. Rathi, Pichai Raman, Jennifer Pogoriler, Tricia Bhatti, Bruce Pawel, Tina Glisovic-Aplenc, Beverly Teicher, Stephen W. Erickson, Eric J. Earley, Kristopher R. Bosse, Poul H. Sorensen, Kateryna Krytska, Yael P. Mosse, Karin E. Havenith, Francesca Zammarchi, Patrick H. van Berkel, Malcolm A. Smith, Benjamin A. Garcia, John M. Maris, Sharon J. Diskin
bioRxiv 2023.12.06.570390; doi: https://doi.org/10.1101/2023.12.06.570390